UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome

Leukemia, 1997, Vol.11 (1), p.1-5

1997

Volltextzugriff (PDF)

Report of an international working group to standardize response criteria for myelodysplastic syndromes

Blood, 2000-12, Vol.96 (12), p.3671-3674

2000

Volltextzugriff (PDF)

Superiority of prolonged low-dose azanucleoside administration? : Results of 5-aza-2' -deoxycytidine retreatment in high-risk myelodysplasia patients

Cancer, 2006-04, Vol.106 (8), p.1744-1750

2006

Volltextzugriff (PDF)

International Prognostic Index for Aggressive Non-Hodgkin's Lymphoma Is Valid for All Malignancy Grades

Blood, 1995-08, Vol.86 (4), p.1460-1463

1995

Volltextzugriff (PDF)

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients

Annals of hematology, 2005-12, Vol.84 Suppl 1 (S1), p.9-17

2005

Volltextzugriff (PDF)

The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes

Leukemia research, 2004-08, Vol.28 (8), p.785-790

2004

Volltextzugriff (PDF)

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

British journal of haematology, 1998-10, Vol.103 (1), p.205-212

1998

Volltextzugriff (PDF)

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

BMJ, 1998-03, Vol.316 (7135), p.894-898

Collaboration, H. L. T.

International edition, 1998

Volltextzugriff (PDF)

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

The Lancet (British edition), 1995-04, Vol.345 (8954), p.882-885

1995

Volltextzugriff (PDF)

DNA methylation as a therapeutic target in hematologic disorders: Recent results in older patients with myelodysplasia and acute myeloid leukemia

International journal of hematology, 2004-08, Vol.80 (2), p.128-135

2004

Volltextzugriff (PDF)

Interferon-α as maintenance therapy in patients with multiple myeloma

Annals of oncology, 2005-04, Vol.16 (4), p.634-639

2005

Volltextzugriff (PDF)

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

Arteriosclerosis, thrombosis, and vascular biology, 1998-03, Vol.18 (3), p.356-361

1998

Volltextzugriff (PDF)

Decitabine in Myelodysplastic Syndromes

Seminars in hematology, 2005-07, Vol.42 (3 Suppl 2), p.S23-S31

2005

Volltextzugriff (PDF)

Impact of Three Courses of Intensified CHOP Prior to High-Dose Sequential Therapy Followed by Autologous Stem-Cell Transplantation As First-Line Treatment in Poor-Risk, Aggressive Non-Hodgkin's Lymphoma: Comparative Analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40

Journal of clinical oncology, 2005-06, Vol.23 (16), p.3793-3801

2005

Volltextzugriff (PDF)

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:: A randomised phase II trial from HOVON, the Dutch–Belgian Haemato-Oncology Working Group for adults

Leukemia research, 2004-10, Vol.28 (10), p.1057-1067

2004

Volltextzugriff (PDF)

Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer

Thrombosis research, 2005, Vol.115 (5), p.381-386

2005

Volltextzugriff (PDF)

Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas

Leukemia, 2005-01, Vol.19 (1), p.143-145

2005

Volltextzugriff (PDF)

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma

Haematologica (Roma), 2005-10, Vol.90 (10), p.1422-1432

2005

Volltextzugriff (PDF)

Early response to therapy and survival in multiple myeloma

British journal of haematology, 2004-04, Vol.125 (2), p.162-166

2004

Volltextzugriff (PDF)

Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands

Annals of oncology, 1998-11, Vol.9 (11), p.1219-1227

1998

Volltextzugriff (PDF)

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry

Annals of oncology, 2002-08, Vol.13 (8), p.1275-1284

2002

Volltextzugriff (PDF)

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma

British journal of haematology, 1999-04, Vol.105 (1), p.127-130

1999

Volltextzugriff (PDF)

Disappearance of a mucosa‐associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori

European journal of haematology, 2002-03, Vol.68 (3), p.187-188

2002

Volltextzugriff (PDF)

Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemia

Haematologica (Roma), 2005-10, Vol.90 (10), p.1437-1438

2005

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(60)
Science & Technology
(60)
Humans
(56)
Biological And Medical Sciences
(42)
Hematology
(42)
Medical Sciences
(41)
Male
(36)
Female
(33)
Middle Aged
(32)
Aged
(29)
Adult
(26)
Oncology
(19)
Pharmacology. Drug Treatments
(17)
Hematologic And Hematopoietic Diseases
(16)
Aged, 80 And Over
(15)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(14)
Antineoplastic Agents
(11)
Prognosis
(11)
Chemotherapy
(9)
Myelodysplastic Syndromes - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome

Report of an international working group to standardize response criteria for myelodysplastic syndromes

Superiority of prolonged low-dose azanucleoside administration? : Results of 5-aza-2' -deoxycytidine retreatment in high-risk myelodysplasia patients

International Prognostic Index for Aggressive Non-Hodgkin's Lymphoma Is Valid for All Malignancy Grades

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients

The effects of 5-aza-2′-deoxycytidine (Decitabine) on the platelet count in patients with intermediate and high-risk myelodysplastic syndromes

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

DNA methylation as a therapeutic target in hematologic disorders: Recent results in older patients with myelodysplasia and acute myeloid leukemia

Interferon-α as maintenance therapy in patients with multiple myeloma

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

Decitabine in Myelodysplastic Syndromes

Impact of Three Courses of Intensified CHOP Prior to High-Dose Sequential Therapy Followed by Autologous Stem-Cell Transplantation As First-Line Treatment in Poor-Risk, Aggressive Non-Hodgkin's Lymphoma: Comparative Analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40

Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia:: A randomised phase II trial from HOVON, the Dutch–Belgian Haemato-Oncology Working Group for adults

Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer

Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas

Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma

Early response to therapy and survival in multiple myeloma

Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’s lymphoma registry

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma

Disappearance of a mucosa‐associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori

Serum syndecan-1 in patients with newly diagnosed monoclonal proteinemia

Suchergebnisse filtern